Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
Open Access
- 4 January 2019
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 19 (1) , 1-7
Abstract
Many newborns may need to be hospitalized and receive drugs during the first days of their lives. These drugs are fundamentally prescribed as off-label and unlicensed. This study aimed to investigate the amount of these kinds of drugs administered in the Neonatal Intensive Care Units (NICUs) of Abuzar and Imam Khomeini Teaching Hospitals in Ahvaz, Iran. This was a 3-month descriptive, cross-sectional study with retrospective nature in which 193 hospitalized newborns were studied. Demographic data were extracted from the patients’ files. The drugs were classified as off-label, unlicensed or licensed according to the Pediatric & Neonatal Dosage Handbook (Lexicomp®, 22nd Edition). In total, 1049 prescriptions were registered for the 193 hospitalized newborns (term and preterm). For each newborn, the mean numbers of prescriptions and drugs received were 5.4 and 4.5, respectively. The mean numbers of prescriptions and drugs were greater for preterm newborns. Of the total 1049 prescriptions, 38.1% were off-label and 1.9% were unlicensed. Of the 193 newborns, 85% received at least one off-label or unlicensed prescription. Off-label prescriptions were mostly related to dose (44.8%) and dosing interval (36.5%). Most off-label drugs were antibiotics (mainly Gentamicin). Albuterol was used off-label in 100% of the cases. The results of the present study show that the prescription of off-label and unlicensed drugs in NICUs is as high in Iran as in other countries. This suggests that it is necessary to provide information to neonatologists to decrease the prescription of off-label and unlicensed drugs.Keywords
This publication has 27 references indexed in Scilit:
- Drug utilisation pattern and off-label use of medicines in Estonian neonatal unitsEuropean Journal of Clinical Pharmacology, 2011
- Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and futureExpert Opinion on Drug Safety, 2011
- Drug treatments in a neonatal setting: focus on the off-label use in the first month of lifePharmacy World & Science, 2010
- Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literatureJournal of Clinical Pharmacy and Therapeutics, 2009
- Medication Use in the Neonatal Intensive Care Unit: Current Patterns and Off-Label Use of Parenteral MedicationsThe Journal of Pediatrics, 2008
- Unlicensed and off-label use of medicines at a neonatology clinic in ItalyPharmacy World & Science, 2007
- Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safetyExpert Opinion on Drug Safety, 2006
- A literature review on off-label drug use in childrenEuropean Journal of Pediatrics, 2005
- Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and ChildrenNew England Journal of Medicine, 2003
- Unlicensed and Off-Label Drug Use in an Australian Neonatal Intensive Care UnitPediatrics, 2002